An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment

American Journal of Gastroenterology

Volumn 104, Issue 12, 2009, Pages 2990-2995

  Sakuraba, Atsushi ^a   Motoya, Satoshi ^b   Watanabe, Kenji ^c   Nishishita, Masakazu ^d   Kanke, Kazunari ^e   Matsui, Toshiyuki ^f   Suzuki, Yasuo ^g   Oshima, Tadayuki ^h   Kunisaki, Reiko ⁱ   Matsumoto, Takayuki ^j   Hanai, Hiroyuki ^k   Fukunaga, Ken ^l   Yoshimura, Naoki ^m   Chiba, Toshimi ⁿ   Funakoshi, Shinsuke ^o   Aoyama, Nobuo ^p   Andoh, Akira ^q   Nakase, Hiroshi ^r   Mizuta, Yohei ^s   Suzuki, Ryoichi ^t   Akamatsu, Taiji ^u   Iizuka, Masahiro ^v   Ashida, Toshifumi ^w   Hibi, Toshifumi ^a   more..

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sapporo Kosei General Hospital   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Nishishita Hospital of Gastroenterology   (Japan)

^e DOKKYO MEDICAL UNIVERSITY   (Japan)

^f Fukuoka University Chikushi Hospital   (Japan)

^g TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^h NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

ⁱ YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^j KYUSHU UNIVERSITY   (Japan)

^k Kakegawa General Hospital   (Japan)

^l HYOGO COLLEGE OF MEDICINE   (Japan)

^m CHIBA UNIVERSITY   (Japan)

ⁿ IWATE MEDICAL UNIVERSITY   (Japan)

^o KITASATO INSTITUTE HOSPITAL   (Japan)

^p KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^r KYOTO UNIVERSITY   (Japan)

^s NAGASAKI UNIVERSITY   (Japan)

^t Kannai Suzuki Clinic   (Japan)

^u SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^v AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^w ASAHIKAWA MEDICAL COLLEGE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GRANULOCYTE MONOCYTE ADSORPTIVE APHERESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SAFETY; TREATMENT DURATION; ULCERATIVE COLITIS;

ADOLESCENT; ADSORPTION; ADULT; AGED; BLOOD COMPONENT REMOVAL; COLITIS, ULCERATIVE; FEMALE; GRANULOCYTES; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; REMISSION INDUCTION; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 72949090370     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.453     Document Type: Article

References (29)

1. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002;15:79-94.
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434
3. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-1581
4. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992;13:169-172
5. Cassatella MA, Meda L, Gasperini S et al. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol 1995;25:1-5.
6. McCarthy DA, Rampton DS, Liu YC. Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol 1991;86:489-493
7. Meuret G, Bitzi A, Hammer B. Macrophage turnover in Crohn's disease and ulcerative colitis. Gastroenterology 1978;74:501-503
8. Saniabadi AR, Hanai H, Takeuchi K et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of in-flammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003;7:48-59.
9. Brannigan AE, O'Connell PR, Hurley H et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 2000;13:361-366
10. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000;51:289-298
11. Schreiber S, Nikolaus S, Hampe J et al. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet 1999;353:459-461
12. Nikolaus S, Bauditz J, Gionchetti P et al. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998;42:470-476
13. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-1629
14. Rachmilewitz D, Karmeli F, Schwartz LW et al. Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation. Gut 1992;33:929-932
15. Hanauer SB, Stathopoulos G. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease. Drug Saf 1991;6:192-219.
16. Gionchetti P, Rizzello F, Habal F et al. Standard treatment of ulcerative colitis. Dig Dis 2003;21:157-167
17. Card T, West J, Hubbard R et al. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004;53:251-255
18. Kornbluth A, Marion JF, Salomon P et al. How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol 1995;20:280-284
19. Taffet SL, Das KM. Sulfasalazine. Adverse effects and desensitization. Dig Dis Sci 1983;28:833-842
20. Shimoyama T, Sawada K, Hiwatashi N et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001;16:1-9.
21. Fukuda Y, Matsui T, Suzuki Y et al. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J Gastroenterol 2004;39:1158-1164
22. Fujimori J, Yoshino S, Koiwa M et al. Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1. Rheumatol Int 1996;15:175-180
23. Hibi T, Sakuraba A. Is there a role for apheresis in gastrointestinal disorders? Nat Clin Pract Gastroenterol Hepatol 2005;2:200-201
24. Sakuraba A, Sato T, Naganuma M et al. A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis. J Gastroenterol 2008;43:51-56
25. Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-1845
26. Naganuma M, Funakoshi S, Sakuraba A et al. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or-dependent ulcerative colitis. Inflamm Bowel Dis 2004;10:251-257
27. Sands BE, Sandborn WJ, Feagan B et al. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology 2008;135:400-409
28. Maiden L, Takeuchi K, Baur R et al. Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse. Inflamm Bowel Dis 2008;14:1413-1418
29. Iwakami Y, Sakuraba A, Takada Y et al. Granulocyte and monocyte adsorption apheresis modulates monocyte dereived dendritic cell function in patients with active ulcerative colitis. Ther Apher Dial 2009;13:138-146